Related content

Prediction of risk for symptomatic sialadenitis by post-therapeutic dual ¹³¹I scintigraphy in patients with differentiated thyroid cancer

By Lee Sang   Lee Jeong   Kim Shin   Han Seon   Bae Won  

Annals of Nuclear Medicine, Vol. 27, Iss. 8, 2013-10 ,pp. : 700-709

Springer Publishing Company

Access to resources Recommend Favorite

Is radioiodine treatment for thyroid cancer a risk factor for second primary malignancies?

By Dottorini Massimo  

Clinical and Translational Imaging, Vol. 1, Iss. 3, 2013-06 ,pp. : 205-216

Springer Publishing Company

Access to resources Recommend Favorite

An Investigation of the Effects of Late-Onset Dietary Restriction on Prostate Cancer Development in the TRAMP Mouse

By Suttie Andrew   Dinse Gregg   Nyska Abraham   Moser Glenda   Goldsworthy Thomas   Maronpot Robert  

Toxicologic Pathology, Vol. 33, Iss. 3, 2005-01 ,pp. : 386-397

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET

By Eschmann Susanne   Reischl Gerald   Bilger Kilian   Kupferschläger Juergen   Thelen Marcel   Dohmen Bernhard   Besenfelder Hariolf   Bares Roland  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 29, Iss. 6, 2002-06 ,pp. : 760-767

Springer Publishing Company

Access to resources Recommend Favorite

Design of patient rooms and automatic radioiodine-131 waste water management system for a thyroid cancer treatment ward: ‘Suandok model’

By Vilasdechanon N   Ua-apisitwong S   Chatnampet K   Ekmahachai M   Vilasdechanon J  

Journal of Radiological Protection, Vol. 34, Iss. 3, 2014-09 ,pp. : 699-708

IOP Publishing

Access to resources Recommend Favorite